Clinical, epidemiological, pathologic and surgical characteristics of patients with thyroid cancer
Keywords:
ultrasonography, thyroid neoplasms, cytodiagnosis, thyroidectomy.Abstract
Introduction: The thyroid cancer constitutes a reason of great concern and repercussion for the health of these patients. Once the diagnosis is confirmed, a treatment protocol is initiated that generates major physical, psychological and social impacts.
Objective: To characterize patients with thyroid cancer according to clinical, epidemiologic, pathologic and surgical variables.
Method: A descriptive, observational, cross-sectional and retrospective study, was carried out on 153 patients surgically intervened with thyroid cancer, from January, 2012 to December, 2019. The instrument used was the quantitative observational and was processed by means of the statistical system SPSS, version 22.0.
Results: In the series there was a prevalence of the sixth decade of life (37.2 %) and female sex (89.5 %). Of the patients, 97.4 % suffered from a comorbidity and 27.4 % were exposed to risk factors of malignancy. Likewise, 64.7 % didn't have ganglionar metastasis and were operated before the year of the diagnosis. The multinodularity had an effect in the most frequent clinical form with 52.2 %. There was a prevalence of the echographic report TIRADS V (64.0 %) and the cytologic Bethesda VI (45.6 %). The predominant histological variety was papillary (54.9 %). There was a prevalence of the total thyroidectomy (78.5 %) and dysphonia as a complication (6.0 %).
Conclusions: The thyroid cancer is still a health problem and when characterizing these patients there was contribution to improve the opportune diagnosis and the personalization of therapy in each patient.
Downloads
References
2. Pizzato M, Vignat J, Laversanne M, Singh D, La Vecchia C. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022 [citado 17/07/2024];10(4):264-72. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2213858722000353?via%3Dihub
3. Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China. J. Natl. Cancer Cent. 2022 [citado 27/07/2024];4(1):47-53. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC11256708/
4. Bravo-Villalta RR, Zambrano-Rodríguez KA, Durán-Cañarte AL. Prevalencia, factores de riesgo y diagnóstico del cáncer de tiroides en la población de América Latina. MQRInvestigar. 2024 citado 27/07/2024];8(1):2365-82. Disponible en: https://www.investigarmqr.com/ojs/index.php/mqr/article/view/1004/3786
5. Siegel RL, Miller KD, Giaquinto AN, Jemal A. Cancer statistics. CA Cancer J Clin. 2024 [citado 27/07/2024];74(1):13-49. Disponible en: https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21820?src=getftr
6. Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España. 2024 [citado 27/07/2024]. Disponible en: https://seom.org/images/publicaciones/informes-seom-de-evaluacion-de-farmacos/LAS_CIFRAS_2024.pdf
7. República de Cuba. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2023. La Habana: MINSAP. 2023 [citado 27/07/2024]. Disponible en: https://instituciones.sld.cu/ucmvc/files/2023/10/Anuario-Estad%C3%ADstico-de-Salud-2022-Ed-2023.pdf
8. Bogović Crnčić T, Ilić Tomaš M, Girotto N, Grbac Ivanković S. Risk factors for thyroid cancer: What do we know so far? Acta Clin Croat. 2020 [citado 27/07/2024];59(1):66-72. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC8212601/
9. Hoang JK, Middleton WD, Tessler FN. Update on ACR TI-RADS: Successes, challenges, and future directions, from the AJR Special Series on Radiology Reporting and Data Systems. AJR Am J Roentgenol. 2021 [citado 27/07/2024];216(3):570–8. Disponible en:
https://www.ajronline.org/doi/10.2214/AJR.20.24608
10. Kraus Fischer G, Alvarado Bachmann R, de Rienzo Madero B, Núñez García E, Vega de la Peña M, Zerrweck López C. Correlación entre el sistema Bethesda de nódulos tiroideos y el diagnóstico histopatológico pos tiroidectomía. Rev Med Inst Mex Seguro Soc. 2020 [citado 16/08/2022];58(2):114-21. Disponible en: https://www.redalyc.org/journal/4577/457767703008/html/
11. The International Classification of Diseases, 10th Revision, Clinical modification. The National Center for Health Statistics (NHCS). 2024 [citado 27/07/2024]. Disponible en: https://www.cdc.gov/nchs/icd/icd-10-cm/index.html
12. Cruz OM, Pérez RM, Jenaro RC, Flores RN, Torres AA. Implicaciones éticas para la investigación: El interminable reto en un mundo que se transforma. Horiz. Sanitario. 2020 [citado 16/08/2022];19(1):9-17. Disponible en: https://gredos.usal.es/bitstream/handle/10366/152135/2007-7459-hs-19-01-9.pdf?sequence=1&isAllowed=y
13. Puerto-Lorenzo J, Torres-Aja L, Cabanes-Rojas E. Cáncer de tiroides: comportamiento en Cienfuegos. Rev Finlay.2018 [citado 03/07/2024];8(2):94-102. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/444
14. Vera Ochoa JF, Suárez Lescano HB, Pilamunga Valla ER, Ortiz Álvarez MD, Montúfar Benítez OI. Cáncer de tiroides: perfil clínico-epidemiológico. 2023 [citado 16/07/2024];6(1). Disponible en: https://jah-journal.com/index.php/jah/article/view/158
15. Arias-Ortiz NE, Guzmán Gallego EA. Características clínicas del cáncer de tiroides en Manizales, Colombia, 2008-2015. Rev Peru Med Exp Salud Pública. 2020 [citado 16/07/2024];37(2):287-91. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342020000200287
16. Ortega-Peñate J, Díaz-Alfonso O, Cora-Abraham J, Méndez-Fleitas L, Ortega-Rodríguez Y. Comportamiento clínico-epidemiológico del cáncer de tiroides. Rev Méd Electrónica. 2020 [citado 31/03/2022];42(6): Disponible en:
https://revmedicaelectronica.sld.cu/index.php/rme/article/view/3979/pdf_836
17. Acosta Guerrero Gleidys, Delgado Llorca Fred, Ricardo Martínez Daimí, Guerra Corría Yamila. Caracterización clínica y epidemiológica de pacientes operados por cáncer de tiroides. Multimed. 2022 [citado 03/07/2024];26(1).
Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1028-48182022000100008&lng=es
18. Mauri G, Gitto S, Cantisani V, Vallone G, Schiavone C, Papini E, et al. Use of the thyroid imaging reporting and data system (TIRADS) in clinical practice: an Italian survey. Endocrine. 2020 [citado 16/07/2024];68(2):329–35. Disponible en: https://link.springer.com/article/10.1007/s12020-020-02199-3
19. Bujaidar Tobias FA, Zatarain Bayliss L, Dehesa López E, Peraza Garay FJ. Incidencia de malignidad en nódulos tiroideos en pacientes sometidos a biopsia por aspiración con aguja fina guiada por ultrasonido. Rev Med UAS. 2020 [citado 16/08/2022];10(3):127-34. Disponible en: https://hospital.uas.edu.mx/revmeduas/articulos/v10/n3/tiroideos.pdf
20. Escalona-Veloz R. Utilización del sistema Bethesda para el diagnóstico citológico de nódulos tiroideos. MEDISAN. 2023 [citado 15/07/2024];27(1) Disponible en: https://medisan.sld.cu/index.php/san/article/view/3395/pdf
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
